| # | Drug | Count |
|---|---|---|
| 0 | PEGINTERFERON ALFA-2A | 15 |
| 1 | RIBAVIRIN | 15 |
| 2 | GLECAPREVIR AND PIBRENTASVIR | 6 |
| 3 | ELBASVIR AND GRAZOPREVIR | 5 |
| 4 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 5 |
| 5 | DARUNAVIR | 4 |
| 6 | FERROUS SULFATE | 4 |
| 7 | RITONAVIR | 4 |
| 8 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 |
| 9 | SOFOSBUVIR | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELBASVIR AND GRAZOPREVIR | 5 | 0.0012 |
| 1 | DARUNAVIR ETHANOLATE AND COBICISTAT | 2 | 0.0011 |
| 2 | GLECAPREVIR AND PIBRENTASVIR | 6 | 0.0005 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 3 | 0.0005 |
| 4 | MARIBAVIR | 1 | 0.0004 |
| 5 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 6 | DARUNAVIR | 4 | 0.0003 |
| 7 | NALOXEGOL OXALATE | 1 | 0.0003 |
| 8 | RIBAVIRIN | 15 | 0.0002 |
| 9 | RALTEGRAVIR | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 11 | 0.0007 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Hepatitis C Virus NS5A Inhibitor [EPC] | 13 | 0.0003 |
| 3 | Nucleoside Analog Antiviral [EPC] | 15 | 0.0002 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 8 | 0.0001 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0001 |
| 6 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 5 | 0.0001 |
| 7 | Protease Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 9 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |